VivoSim Labs, Inc.
VIVS · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $144 | $109 | $370 | $1,500 |
| % Growth | 32.1% | -70.5% | -75.3% | – |
| Cost of Goods Sold | $5 | $0 | $0 | $0 |
| Gross Profit | $139 | $109 | $370 | $1,500 |
| % Margin | 96.5% | 100% | 100% | 100% |
| R&D Expenses | $5,025 | $5,498 | $8,885 | $3,320 |
| G&A Expenses | $7,691 | $9,644 | $9,088 | $9,631 |
| SG&A Expenses | $7,691 | $9,644 | $9,088 | $9,631 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $39 | $53 | $128 | $28 |
| Operating Expenses | $12,755 | $15,195 | $18,101 | $12,979 |
| Operating Income | -$12,616 | -$15,086 | -$17,731 | -$11,479 |
| % Margin | -8,761.1% | -13,840.4% | -4,792.2% | -765.3% |
| Other Income/Exp. Net | $10,130 | $417 | $474 | $33 |
| Pre-Tax Income | -$2,486 | -$14,669 | -$17,257 | -$11,446 |
| Tax Expense | $2 | $2 | $2 | $2 |
| Net Income | -$2,488 | -$14,671 | -$17,259 | -$11,448 |
| % Margin | -1,727.8% | -13,459.6% | -4,664.6% | -763.2% |
| EPS | -1.7 | -19.25 | -23.76 | -15.84 |
| % Growth | 91.2% | 19% | -50% | – |
| EPS Diluted | -1.7 | -19.25 | -23.76 | -15.84 |
| Weighted Avg Shares Out | 1,464 | 762 | 726 | 725 |
| Weighted Avg Shares Out Dil | 1,464 | 762 | 726 | 725 |
| Supplemental Information | – | – | – | – |
| Interest Income | $140 | $405 | $454 | $8 |
| Interest Expense | $10 | $0 | $0 | $0 |
| Depreciation & Amortization | $266 | $280 | $293 | $142 |
| EBITDA | -$2,210 | -$14,806 | -$17,438 | -$11,337 |
| % Margin | -1,534.7% | -13,583.5% | -4,713% | -755.8% |